BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Revenue

In the year 2024, BioRestorative Therapies had annual revenue of $401.00K with 175.03% growth. BioRestorative Therapies had revenue of $43.30K in the quarter ending December 31, 2024, with 124.35% growth.

• Revenue (ttm): $401.00K
• Revenue Growth: +175.03%
• P/S Ratio: 32.91
• Revenue / Employee: $36,455
• Employees: 11
• Market Cap: 12.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	401.00K	255.20K	175.03%
Dec 31, 2023	145.80K	26.00K	21.70%
Dec 31, 2022	119.80K	73.80K	160.43%
Dec 31, 2021	46.00K	-31.00K	-40.26%
Dec 31, 2020	77.00K	-53.00K	-40.77%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.